Simpson Thacher represents Karuna Therapeutics in its $14 billion acquisition by Bristol-Myers Squibb.

The Sponsor

Loading page...

Simpson Thacher represents Karuna Therapeutics in its $14 billion acquisition by Bristol-Myers Squibb. | The Sponsor - The Sponsor